28th Mar 2008 07:01
Sinclair Pharma PLC28 March 2008 Sinclair Pharma plc (the "Company") The Company was informed on 27th March 2008 that Dr. Michael Flynn, ChiefExecutive Officer, acquired 2,042 ordinary shares of 1p each in the Company ("Ordinary Shares") at an average price of 33.2 pence per share on 27th March2008. Following this acquisition of Ordinary Shares Dr. Flynn has an interest in atotal of 9,508,000 Ordinary Shares equalling approximately 10.2 per cent. of theissued share capital in the Company. For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600Jerry Randall, CFO This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma